Search research articles
Contact Us
Filters
Showing results (61-70 of 108) with videos related to
Page
of 11
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
July 26, 2013
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies
Giovanni Vitale, Giovanni Lupoli, Rosario Guarrasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2009
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance
Raffaele Addeo, Michele Caraglia, Sergio Bellini, et al.
Future Oncology (London, England)
|
November 20, 2015
Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development
Marina E Cazzaniga, Andrea Camerini, Raffaele Addeo, et al.
International Journal of Molecular Sciences
|
July 13, 2024
TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities
Morena Fasano, Mario Pirozzi, Chiara Carmen Miceli, et al.
Journal of Neuro-Oncology
|
August 10, 2010
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
Raffaele Addeo, Michele Caraglia, M Serena De Santi, et al.
Expert Opinion on Biological Therapy
|
June 19, 2009
Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patients
Bruno Vincenzi, Daniele Santini, Fotios Loupakis, et al.
Journal of Translational Medicine
|
October 22, 2014
The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014
Paolo A Ascierto, Raffaele Addeo, Giacomo Cartenì, et al.
Cancer Chemotherapy and Pharmacology
|
July 13, 2005
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours
Michele Caraglia, Raffaele Addeo, Raffaele Costanzo, et al.
Future Oncology (London, England)
|
October 27, 2016
Adherence and safety of regorafenib for patients with metastatic colorectal cancer: observational real-life study
Salvatore Del Prete, Gregorio Cennamo, Luigi Leo, et al.
World Journal of Oncology
|
August 5, 2021
Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuximab)
Rossella De Luca, Gianluca Lo Coco, Raffaele Addeo, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 108) with videos related to
Sort By:
Page
of 11
The Journal of Clinical Endocrinology and Metabolism
|
July 26, 2013
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies
Giovanni Vitale, Giovanni Lupoli, Rosario Guarrasi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2009
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance
Raffaele Addeo, Michele Caraglia, Sergio Bellini, et al.
Future Oncology (London, England)
|
November 20, 2015
Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development
Marina E Cazzaniga, Andrea Camerini, Raffaele Addeo, et al.
International Journal of Molecular Sciences
|
July 13, 2024
TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities
Morena Fasano, Mario Pirozzi, Chiara Carmen Miceli, et al.
Journal of Neuro-Oncology
|
August 10, 2010
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
Raffaele Addeo, Michele Caraglia, M Serena De Santi, et al.
Expert Opinion on Biological Therapy
|
June 19, 2009
Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patients
Bruno Vincenzi, Daniele Santini, Fotios Loupakis, et al.
Journal of Translational Medicine
|
October 22, 2014
The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014
Paolo A Ascierto, Raffaele Addeo, Giacomo Cartenì, et al.
Cancer Chemotherapy and Pharmacology
|
July 13, 2005
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours
Michele Caraglia, Raffaele Addeo, Raffaele Costanzo, et al.
Future Oncology (London, England)
|
October 27, 2016
Adherence and safety of regorafenib for patients with metastatic colorectal cancer: observational real-life study
Salvatore Del Prete, Gregorio Cennamo, Luigi Leo, et al.
World Journal of Oncology
|
August 5, 2021
Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuximab)
Rossella De Luca, Gianluca Lo Coco, Raffaele Addeo, et al.
Page
of 11